NII, is developing AdFalciVax—India’s first recombinant chimeric malaria vaccine. It targets two key stages of Plasmodium ...

A new hope for India to curb vector-borne disease, the first indigenous malaria vaccine has reportedly shown excellent ...

India has taken a major step forward in the fight against malaria with the development of a new indigenous vaccine candidate ...

ICMR-developed vaccine targets two parasite stages, offers potential for long-term immunity and lower transmission ...

India's ICMR has developed AdFalciVax, a recombinant malaria vaccine targeting two critical stages of Plasmodium falciparum. Showing promise in preclinical trials, it aims to reduce transmission and ...

AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing ...

The Indian Council of Medical Research (ICMR) has invited Expression of Interest (EoI) from eligible organizations, companies, and manufacturers for the transfer of technology related to a new malaria ...

This vaccine will be the first indigenous recombinant chimeric malaria vaccine that will be specifically designed to target two critical stages of Plasmodium falciparum, the parasite responsible for ...